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not independently predictive on multivariate analysis. In addition,
there was no association between erythrocyte sedimentation rate
and mortality.
The finding of thrombocytopenia in patients with endocarditis
has clinical implications. First, patients presenting with thrombo-
cytopenia should receive empirical antistaphylococcal therapy be-
cause of the strong association between baseline thrombocytopenia
and Staphylococcus aureus infection. Second, if antiplatelet agents
are being considered as adjunctive therapy (4), clinicians should
exclude coexistent thrombocytopenia because of its potential to
increase the risk of bleeding. Third, thrombocytopenia at day 8
indicates an impaired host response to sepsis and predicts increased
mortality. In this setting, patients with thrombocytopenia may
warrant more intensive monitoring, alterations to treatment, and,
where relevant, consideration of surgery.
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Letters to the Editor
Perioperative Myocardial
Infarction Has Been Forgotten
Thygesen et al. (1) have published a consensus report that reviews
the definition of myocardial infarction (MI) and proposes a new
classification of 5 categories based on differences in pathophysiol-
ogy. We believe that this definition is flawed in 1 respect: it does
not mention perioperative MI. This is not the first time that a MI
definition has been questioned. When the consensus document of
the Joint European Society of Cardiology/American College of
Cardiology redefinition of MI was released, Tunstall-Pedoe (2)
Figure 1 Severity of Thrombocytopenia
Is Associated With 6-Month Mortality
Six-month mortality in relation to platelet count at day 1 (A) and at day 8 (B).
The total number of patients within each band of platelet counts is indicated
by n. Chi-square test for trend p  0.001 at day 1 and day 8.
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indicated several problems with that document. Some of those
problems have been solved in this new classification (e.g., the
inclusion of fatal cases of MI). This new classification includes
spontaneous MI (type 1), MI secondary to ischemia due to either
increased oxygen demand or reduced supply (type 2), sudden
cardiac deaths or cardiac arrest (type 3), MI associated with
percutaneous coronary intervention (type 4), and MI associated
with coronary artery bypass grafting (type 5). This classification
could be useful to develop future studies analyzing different
treatments according to the group to which the patient belongs.
However, it is our opinion that an important group of patients has
been forgotten: those with MI related to noncardiac surgeries. The
etiology and pathophysiology of myocardial ischemia and infarc-
tion in this setting are still controversial subjects and could fit
either in types 1 or 2. Based on pathology studies (3,4), we believe
that perioperative MI have similar pathophysiology to spontaneous
MI; therefore, they should be treated the same way. As a
complement of Thygesen’s classification, we suggest the inclusion
of MI after noncardiac surgeries in type 1 MI of the new
classification because this inclusion may have implications for the
management of acute coronary syndromes in this setting.
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Reply
We thank Dr. Gualandro and colleagues for their thoughtful
letter. We have considered a number of different clinical scenarios
but decided not to target every specific clinical situation, because
there are too many to be contained within the framework of the
European Society of Cardiology/American College of Cardiology
Foundation/American Heart Association/World Heart Federation
expert consensus document (1).
We agree that there is a great deal to learn about perioperative
myocardial infarctions as the pathophysiology of these differs
somewhat from that of myocardial infarction occurring in the usual
setting. We also agree that it can be hard to tell whether these
infarctions are type 1 or type 2. However, there are some data to
guide us.
Studies of patients undergoing noncardiac surgery strongly
support the concept that many of the infarctions diagnosed in this
connection are caused by prolonged imbalance between myocardial
oxygen supply and demand on the background of coronary artery
disease (2,3), which together with rise and fall of cardiac markers
points toward myocardial infarction type 2.
The fact that many such patients have type 2 infarctions should
not obscure the likelihood that some of the infarctions are type 1
as well. Pathology of fatal peri- or post-operative myocardial
infarctions shows plaque rupture and platelet aggregation leading
to thrombus formation in approximately half of these events (4).
Given the differences that likely exist in the therapeutic approaches
to each, close clinical scrutiny to identify this group is essential.
Some patients may not have myocardial infarction at all. Careful
clinical evaluation including a detailed history, examination, and
evaluation of further investigations to identify and treat those with
pulmonary embolism, sepsis, and/or the many other conditions
associated with myocyte necrosis and troponin elevations is
strongly advocated (1).
Although we cannot make criteria for all clinical judgments
such as this one, the available information suggests that the use of
contemporary troponin assays (5,6) and the decision levels advo-
cated by the expert consensus document (1) maximizes the ability
to identify patients with this diagnosis and then to configure the
care according to the type based on that judgment.
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